As of November 2024, Kiniksa Pharmaceuticals has a market cap of $906.13M. This makes Kiniksa Pharmaceuticals the world's 8286th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $717.05M | 15.45% |
2023 | $621.09M | 17.09% |
2022 | $530.44M | 27.27% |
2021 | $416.77M | -33.39% |
2020 | $625.69M | 59.76% |
2019 | $391.63M | -60.63% |
2018 | $994.66M | - |